Financhill
Back

Intra-Cellular Therapies Stock Predictions

Sell
45

ITCI
Intra-Cellular Therapies

Last Price:
67.73
Seasonality Move:
-1.36%

7 Day Trial

ALL ACCESS PASS

$ 7

Intra-Cellular Therapies Stock Forecast

  • Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 33% based on the past 10 years of stock performance.
  • Intra-Cellular Therapies has risen higher in 8 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
  • Is Intra-Cellular Therapies Stock Undervalued?
    The current Intra-Cellular Therapies [ITCI] share price is $67.77. The Score for ITCI is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • ITCI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Intra-Cellular Therapies Stock Go Up Next Year?

  • Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 33% based on the past 10 years of stock performance.

Intra-Cellular Therapies Stock Rating

Sell
45
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies overpriced?

  • Intra-Cellular Therapies has risen higher in 8 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%

Intra-Cellular Therapies Stock Price History

Is ITCI stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
intracellulartherapies.com

52-Week Data

52-Week High:
84.89
52-Week Low:
45.50

Prediction Charts

Market Cap:
7.15B
Price in USD:
67.77
Volume:
636.04K
Beta:
1.08

Technical Analysis

SMA50:
68.90
SMA100:
68.87
SMA200:
63.76
52-Wk Change:
5.23%

Stock Predictions

  • Is Intra-Cellular Therapies stock public?
    Yes, Intra-Cellular Therapies is a publicly traded company.
  • What is the Intra-Cellular Therapies stock quote today?
    The Intra-Cellular Therapies stock price is 67.77 USD today.
  • How to buy Intra-Cellular Therapies stock online?
    You can buy Intra-Cellular Therapies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-28 65.67 65.61 66.55 65.20
May-29 65.06 66.54 67.09 64.72
May-30 66.66 65.65 67.40 65.15
May-31 66.02 67.24 67.70 65.81
Jun-3 67.42 68.41 70.08 67.30
Jun-4 68.32 67.88 68.61 67.06
Jun-5 68.23 67.81 68.23 66.75
Jun-6 67.69 68.55 68.76 67.04
Jun-7 68.13 68.41 68.75 67.37
Jun-10 68.16 69.07 69.48 67.05
Jun-11 67.62 69.13 69.64 66.89
Jun-12 70.22 68.20 70.43 67.97
Jun-13 68.99 68.37 69.00 67.17
Jun-14 67.66 67.77 69.28 66.57

Intra-Cellular Therapies Earnings

Intra-Cellular Therapies Earnings Report: Per Share Intra-Cellular Therapies Earnings Q1 Q2 Q3 and Q4 last year and next year.

Intra-Cellular Therapies Forecast Revenue Growth

Intra-Cellular Therapies Stock Analysis: Historical quarterly revenues per share for Intra-Cellular Therapies and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.01 per share, an increase this year of $1.11 per share, and an increase next year of $1.43 per share.

* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.